#CDAI is the first choice for measuring treatment effects of disease-modifying #antirheumatic drugs. Using a broad evidence base, a team of IQWiG authors compared measurement tools.

Article in #BMCRheumatology: https://bmcrheumatol.biomedcentral.com/articles/10.1186/s41927-022-00314-7

As we are still missing big chunks of our #EvidenceBasedMedicine community from the birdsite, boosts are much appreciated!

Also: Do you know people, journals and institutions to follow on topics like this?

#arthritis #EULAR #rheuma #rheumatology